Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...
Suzetrigine, now marketed as Journavx, is not the first sodium-channel-targeting drug for pain management. Compounds such as procaine (Novocain) have provided reliable anaesthesia for more than a ...